Down-regulation followed by re-expression of equine CD4 molecules in response to phorbol myristate acetate

Vet Immunol Immunopathol. 1994 Jul;42(1):71-82. doi: 10.1016/0165-2427(94)90090-6.

Abstract

The regulatory effects of phorbol myristate acetate (PMA) on the expression of the CD4 molecule on horse T cells were investigated. On both peripheral blood lymphocytes and thymocytes, PMA resulted in a rapid and transient down-regulation of equine CD4 expression, but had no such effect on the surface expression of equine CD5, CD8 or major histocompatibility complex (MHC) class I and class II molecules. Over 75% of the surface CD4 molecules per cell were lost after a 4 h exposure to PMA at 37 degrees C. The regulation of equine CD4 expression induced by PMA was temperature dependent and reversible. The PMA-mediated loss of CD4 expression was inhibited at 4 degrees C. After 24 h of exposure to PMA, CD4 molecules were re-expressed on the cell surface, even in the continued presence of PMA. These findings demonstrate that equine CD4+ T cells undergo alterations in CD4 expression in response to PMA, and suggest that the equine homolog of the CD4 molecule is regulated by PMA in a similar manner to the human CD4 molecule.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • CD4 Antigens / metabolism*
  • CD4-Positive T-Lymphocytes / drug effects*
  • Down-Regulation / drug effects
  • Flow Cytometry / veterinary
  • Horses / immunology*
  • Lymphocyte Activation / drug effects
  • Temperature
  • Tetradecanoylphorbol Acetate / pharmacology*

Substances

  • CD4 Antigens
  • Tetradecanoylphorbol Acetate